EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING
Recruiting now · Not applicable
Conditions studied: Pregnancy
In brief
This study aims to investigate whether embryo ranking by a fully automated AI tool (iDAScore) results in a similar transfer-to-pregnancy compared to manual embryo ranking by an embryologist. IVF patients who are planned for a freeze-all approach (where all usable embryos are frozen and transferred in later transfer cycles) will be allocated to either the control (ranking by embryologist) or intervention arm (ranking by iDAScore). The frozen embryos will be warmed and transferred one by one, according to their assigned rank. We want to see if the average number of embryo transfers that is needed to achieve a clinical pregnancy (transfer-to-pregnancy) is similar in both groups.
Key facts
- Study ID
- NCT07187934
- Run by
- Universitair Ziekenhuis Brussel
- People needed
- 1325
- Starts
- 2025-12-11
- Expected to finish
- 2029-10-01
- Last updated by the study team
- 2025-12-23
Who can join
Age: 18 and older, up to 42. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- patients undergoing an ICSI/IVF treatment (with donor or own oocytes) that are planned for a 'freeze-all' strategy on day 5
- all types of sperm samples (ejaculated or testicular, fresh or frozen, partner or donor origin)
- Minimum 8 follicles (≥ 12 mm) on last follicular measurement before oocyte retrieval
- 18 ≤ Age ≤ 42 years
- 18 ≤ BMI ≤ 35 kg/m²
- Maximum third IVF/ICSI cycle
- Participants can be included only once in the trial
You may not qualify if…
- Embassy patients
- Use of frozen oocytes
- In vitro maturation (IVM) cycles
- Pre-implantation genetic Testing (PGT) cycles
- Proven untreated intra-uterine pathologies (e.g. Asherman syndrome, adenomysosis)
- Endometriosis stage 3/4
Where it is running
- Brussels IVF, UZ Brussel — Brussels, Brussels Capital, Belgium (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.